Nurse-led education for patients with rheumatoid arthritis or spondyloarthritis, who are beginning biologic disease-modifying antirheumatic drugs, is effective at changing behaviors to prevent adverse events, according to data.
“Biologic disease-modifying antirheumatic drugs (bDMARDs) are effective treatments for inflammatory arthritis but can lead to safety issues, which could be prevented by educating patients,” Catherine Beauvais, MD, of Saint Antoine Hospital, in Paris, and colleagues wrote in RMD Open. “Recommendations regarding safety exist for health professionals,